All comparisons

Educational Wellness Information Only

This platform provides peer-reviewed research summaries and educational content about peptides for wellness and optimization purposes. Nothing on this site is intended as medical advice, diagnosis, or treatment. We do not claim any peptide can diagnose, treat, cure, or prevent any disease. Always consult a licensed healthcare provider before beginning any wellness protocol.

Statements on this site have not been evaluated by the FDA. Compounded preparations are subject to applicable state and federal regulations. Availability and eligibility vary.

Performance comparison

Mecasermin (Increlex) vs Sermorelin

An educational, source-based comparison of Mecasermin (Increlex) and Sermorelin — how each peptide works, what it's researched for, and what to know before going deeper.

IGF-1 · Endocrine
Mecasermin (Increlex)

Recombinant human IGF-1 for severe primary IGF-1 deficiency.

Mechanism

Recombinant human insulin-like growth factor-1 (rhIGF-1) that binds IGF-1 receptors to promote linear growth in children with severe primary IGF-1 deficiency or GH gene deletion with anti-GH antibodies.

Research areas
  • Severe primary IGF-1 deficiency
  • Growth failure with GH gene deletion and neutralizing GH antibodies
Considerations
  • FDA-approved.
  • Hypoglycemia — must be taken with food.
  • Tonsillar hypertrophy, intracranial hypertension reported.
Full Mecasermin (Increlex) profile →
Growth Hormone Axis
Sermorelin

Shorter-acting GHRH analog used in clinical GH research.

Mechanism

A synthetic 29-amino-acid analog representing the active fragment of endogenous GHRH. Stimulates the pituitary to release GH in a physiologic, pulsatile pattern. Previously FDA-approved (Geref) for pediatric GH deficiency diagnosis before discontinuation for commercial reasons.

Research areas
  • Adult GH deficiency
  • Pediatric short stature (historical)
  • Sleep quality and body composition in aging
Considerations
  • No longer commercially available as an FDA-approved drug; available via compounding.
  • Requires physician oversight.
  • Banned in competitive sport.
Full Sermorelin profile →

Mecasermin (Increlex) vs Sermorelin — Key differences

  • Class: Mecasermin (Increlex) is classified as IGF-1 · Endocrine, while Sermorelin is Growth Hormone Axis.
  • Primary research focus: Mecasermin (Increlex)severe primary igf-1 deficiency; Sermorelinadult gh deficiency.
  • Tag: FDA-Approved · Endocrine vs Growth hormone.

Related comparisons